Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsNVST -1.13%80 Equity-to-Asset is 0.55 as of Jun. 2026, which is 8% below its 10-year median of 0.60. GuruFocus rates NVST with a GF Score™ of 80/100 and a GF Value™ of $24.31 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Envista Holdings ranks worse than 60.87% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Envista Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $3,076 Mil. Envista Holdings's Total Assets for the quarter that ended in Jun. 2026 was $5,597 Mil.
Therefore, Envista Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.55.
The historical rank and industry rank for Envista Holdings's Equity-to-Asset or its related term are showing as below:
NVST'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52 Med: 0.6 Max: 0.83
Current: 0.55
During the past 10 years, the highest Equity to Asset Ratio of Envista Holdings was 0.83. The lowest was 0.52. And the median was 0.60.
NVST's Equity-to-Asset is ranked worse than 60.87% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs NVST: 0.55
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Envista Holdings Equity-to-Asset Related Terms
Envista Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Envista Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NVST vs MMSI, ICUI, MMED: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Envista Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Envista Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envista Holdings (NVST) has a Equity-to-Asset of 0.55 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Envista Holdings and its competitors. This is near median its historical median of 0.60. Over the past decade, Envista Holdings' Equity-to-Asset has ranged from 0.52 to 0.83. According to the industry distribution chart, Envista Holdings ranks #518 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 60.9%.
Is Envista Holdings' Equity-to-Asset too high?
Envista Holdings' current Equity-to-Asset of 0.55 is near median its 10-year median of 0.60. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 0.83. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Envista Holdings' value of 0.55 is 14.1% below this industry median. Based on the distribution chart, Envista Holdings ranks #518 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Envista Holdings has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' Equity-to-Asset compare to MMSI and ICUI?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #518 out of 851 companies for Equity-to-Asset. This places Envista Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Envista Holdings' value of 0.55 is 14.1% below this benchmark. Historically, Envista Holdings' own Equity-to-Asset has ranged from 0.52 to 0.83 over the past decade. While the company's 10-year median is 0.60 vs. the industry median of 0.64, Envista Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envista Holdings's current Equity-to-Asset of 0.55 is 14.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Envista Holdings and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envista Holdings's current Equity-to-Asset is 0.55, which is near median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Based on GuruFocus' analysis, Envista Holdings (NVST) is currently considered Modestly Overvalued. The stock's GF Value™ is $24.31, compared to a current price of $27.13 — trading 11.6% above its estimated fair value. The current Equity-to-Asset is 0.55, which is near median its 10-year median of 0.60 and 14.1% below the Medical Devices & Instruments industry median of 0.64. Envista Holdings' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Envista Holdings (NVST), the current Equity-to-Asset is 0.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of $27.13 is trading 11.6% above its estimated GF Value™ of $24.31.
GuruFocus considers Envista Holdings to be Modestly Overvalued.
Key valuation signals for NVST:
Equity-to-Asset: 0.55 (near median its 10-year median of 0.60)
GF Value™: $24.31 vs. price of $27.13 (11.6% above fair value)
Industry Position: 14.1% below the Medical Devices & Instruments median (#518 of 851)
No single metric tells the full story. See the NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for NVST
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVST has been successfully added to your 
